Ascentage Pharma Group International (HK:6855) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ascentage Pharma Group International has appointed Dr. Marc E. Lippman as an independent non-executive director, starting January 2, 2025. Dr. Lippman, a renowned oncologist and professor at Georgetown University, brings extensive experience in breast cancer research and corporate governance. His addition to the board is expected to enhance the company’s strategic direction amidst its business expansion.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.